Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Nicotine Delivery Systems | 24 | 2024 | 73 | 7.780 |
Why?
|
| Smoking Cessation | 16 | 2024 | 252 | 6.930 |
Why?
|
| Tobacco Products | 16 | 2024 | 50 | 5.540 |
Why?
|
| Vaping | 12 | 2022 | 45 | 4.080 |
Why?
|
| Cigarette Smoking | 7 | 2024 | 34 | 3.730 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 11 | 2020 | 70 | 3.160 |
Why?
|
| Social Media | 10 | 2024 | 93 | 3.040 |
Why?
|
| Methamphetamine | 9 | 2021 | 85 | 2.430 |
Why?
|
| Marketing | 7 | 2022 | 23 | 2.420 |
Why?
|
| Central Nervous System Stimulants | 12 | 2018 | 218 | 2.090 |
Why?
|
| Affect | 10 | 2020 | 387 | 1.930 |
Why?
|
| Mindfulness | 2 | 2024 | 12 | 1.880 |
Why?
|
| Emotions | 7 | 2017 | 349 | 1.740 |
Why?
|
| Hallucinogens | 6 | 2016 | 77 | 1.610 |
Why?
|
| Social Behavior | 8 | 2015 | 299 | 1.540 |
Why?
|
| Oxytocin | 5 | 2020 | 72 | 1.540 |
Why?
|
| Ethanol | 4 | 2021 | 250 | 1.470 |
Why?
|
| Flavoring Agents | 6 | 2021 | 11 | 1.420 |
Why?
|
| Video Games | 2 | 2021 | 10 | 1.370 |
Why?
|
| Motivation | 8 | 2022 | 296 | 1.320 |
Why?
|
| Dextroamphetamine | 6 | 2018 | 108 | 1.290 |
Why?
|
| Tobacco Use Disorder | 6 | 2019 | 114 | 1.280 |
Why?
|
| Tobacco Industry | 2 | 2018 | 7 | 1.210 |
Why?
|
| Young Adult | 35 | 2023 | 6288 | 1.190 |
Why?
|
| Smokers | 4 | 2021 | 46 | 1.190 |
Why?
|
| Double-Blind Method | 22 | 2020 | 1714 | 1.160 |
Why?
|
| Nicotine | 9 | 2024 | 199 | 1.100 |
Why?
|
| Smoking | 11 | 2023 | 620 | 1.090 |
Why?
|
| Psychomotor Performance | 7 | 2011 | 496 | 1.070 |
Why?
|
| Adult | 45 | 2024 | 26507 | 1.010 |
Why?
|
| Substance-Related Disorders | 8 | 2019 | 414 | 0.960 |
Why?
|
| Underage Drinking | 3 | 2021 | 3 | 0.960 |
Why?
|
| Adolescent | 31 | 2023 | 9237 | 0.950 |
Why?
|
| Adolescent Behavior | 7 | 2020 | 109 | 0.950 |
Why?
|
| Humans | 82 | 2024 | 89063 | 0.930 |
Why?
|
| Social Facilitation | 2 | 2021 | 8 | 0.930 |
Why?
|
| Students | 5 | 2021 | 169 | 0.910 |
Why?
|
| Tobacco Use Cessation | 1 | 2023 | 7 | 0.900 |
Why?
|
| Dehydroepiandrosterone | 1 | 2023 | 49 | 0.890 |
Why?
|
| Male | 54 | 2024 | 42251 | 0.880 |
Why?
|
| Mobile Applications | 1 | 2023 | 68 | 0.830 |
Why?
|
| Tobacco Use | 7 | 2022 | 27 | 0.820 |
Why?
|
| Female | 54 | 2024 | 46011 | 0.810 |
Why?
|
| Heart Rate | 6 | 2016 | 493 | 0.780 |
Why?
|
| Blood Pressure | 7 | 2016 | 899 | 0.770 |
Why?
|
| Binge Drinking | 1 | 2021 | 13 | 0.750 |
Why?
|
| Self Efficacy | 1 | 2021 | 54 | 0.740 |
Why?
|
| Risk-Taking | 2 | 2021 | 155 | 0.730 |
Why?
|
| Amphetamine-Related Disorders | 3 | 2012 | 27 | 0.720 |
Why?
|
| Healthy Volunteers | 5 | 2018 | 145 | 0.710 |
Why?
|
| Sleep | 4 | 2011 | 452 | 0.690 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2010 | 13 | 0.690 |
Why?
|
| Consumer Behavior | 1 | 2019 | 30 | 0.680 |
Why?
|
| Cognition | 6 | 2015 | 580 | 0.670 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2022 | 46 | 0.660 |
Why?
|
| Personality | 3 | 2015 | 134 | 0.620 |
Why?
|
| Amphetamine | 2 | 2016 | 101 | 0.610 |
Why?
|
| Behavior, Addictive | 2 | 2017 | 134 | 0.600 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2016 | 1940 | 0.600 |
Why?
|
| Surveys and Questionnaires | 13 | 2021 | 2612 | 0.570 |
Why?
|
| Music | 3 | 2022 | 34 | 0.570 |
Why?
|
| Impulsive Behavior | 3 | 2019 | 286 | 0.560 |
Why?
|
| Social Environment | 2 | 2016 | 187 | 0.560 |
Why?
|
| Administration, Intranasal | 9 | 2020 | 136 | 0.550 |
Why?
|
| Marijuana Use | 3 | 2020 | 7 | 0.540 |
Why?
|
| Individuality | 2 | 2018 | 110 | 0.530 |
Why?
|
| Choice Behavior | 3 | 2014 | 160 | 0.480 |
Why?
|
| Serotonin Agents | 1 | 2014 | 12 | 0.470 |
Why?
|
| Empathy | 2 | 2015 | 150 | 0.460 |
Why?
|
| Intention | 3 | 2022 | 51 | 0.440 |
Why?
|
| Alcoholic Intoxication | 1 | 2013 | 32 | 0.430 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2013 | 44 | 0.420 |
Why?
|
| Depression | 4 | 2023 | 503 | 0.380 |
Why?
|
| Cross-Sectional Studies | 6 | 2023 | 1706 | 0.370 |
Why?
|
| Neoplasms | 2 | 2023 | 3035 | 0.370 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 273 | 0.360 |
Why?
|
| Eating | 1 | 2011 | 166 | 0.360 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 131 | 0.350 |
Why?
|
| Health Behavior | 2 | 2022 | 184 | 0.350 |
Why?
|
| Reward | 5 | 2019 | 188 | 0.330 |
Why?
|
| Pyridines | 1 | 2010 | 315 | 0.310 |
Why?
|
| Los Angeles | 5 | 2020 | 28 | 0.300 |
Why?
|
| Internal-External Control | 1 | 2007 | 45 | 0.300 |
Why?
|
| Speech | 2 | 2020 | 85 | 0.290 |
Why?
|
| Psychotropic Drugs | 2 | 2020 | 78 | 0.290 |
Why?
|
| Self Administration | 3 | 2012 | 72 | 0.270 |
Why?
|
| Anxiety Disorders | 3 | 2019 | 152 | 0.270 |
Why?
|
| California | 2 | 2024 | 144 | 0.270 |
Why?
|
| Arousal | 3 | 2018 | 170 | 0.260 |
Why?
|
| Exercise | 2 | 2020 | 322 | 0.260 |
Why?
|
| Anxiety | 2 | 2019 | 308 | 0.250 |
Why?
|
| Nicotine Chewing Gum | 1 | 2024 | 3 | 0.240 |
Why?
|
| Administration, Oral | 4 | 2018 | 682 | 0.240 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2023 | 15 | 0.230 |
Why?
|
| Product Labeling | 2 | 2013 | 3 | 0.220 |
Why?
|
| Alkaloids | 2 | 2013 | 46 | 0.220 |
Why?
|
| Schools | 2 | 2020 | 75 | 0.210 |
Why?
|
| Self Report | 6 | 2020 | 295 | 0.210 |
Why?
|
| Minority Groups | 1 | 2023 | 144 | 0.200 |
Why?
|
| Marijuana Smoking | 2 | 2019 | 28 | 0.200 |
Why?
|
| Sex Factors | 1 | 2024 | 1063 | 0.190 |
Why?
|
| Smoke | 1 | 2021 | 27 | 0.190 |
Why?
|
| Parents | 1 | 2023 | 285 | 0.190 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2021 | 59 | 0.180 |
Why?
|
| Internet | 2 | 2020 | 318 | 0.180 |
Why?
|
| Premenopause | 1 | 2020 | 57 | 0.180 |
Why?
|
| Plants, Edible | 1 | 2019 | 2 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 91 | 0.170 |
Why?
|
| Product Packaging | 1 | 2019 | 1 | 0.170 |
Why?
|
| Aromatherapy | 1 | 2019 | 1 | 0.170 |
Why?
|
| Government Regulation | 1 | 2019 | 49 | 0.170 |
Why?
|
| Mood Disorders | 1 | 2020 | 81 | 0.170 |
Why?
|
| Work Schedule Tolerance | 2 | 2010 | 37 | 0.170 |
Why?
|
| Taste | 1 | 2019 | 28 | 0.170 |
Why?
|
| Cannabis | 1 | 2019 | 35 | 0.170 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 111 | 0.170 |
Why?
|
| Behavior Therapy | 1 | 2020 | 84 | 0.170 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2019 | 56 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 442 | 0.170 |
Why?
|
| Pleasure | 2 | 2015 | 14 | 0.160 |
Why?
|
| Cartoons as Topic | 1 | 2018 | 3 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2019 | 865 | 0.160 |
Why?
|
| Commerce | 1 | 2018 | 31 | 0.160 |
Why?
|
| Middle Aged | 6 | 2024 | 25863 | 0.160 |
Why?
|
| Language | 1 | 2020 | 154 | 0.160 |
Why?
|
| United States | 5 | 2022 | 6955 | 0.160 |
Why?
|
| Economics, Behavioral | 1 | 2018 | 7 | 0.150 |
Why?
|
| Risk Factors | 6 | 2020 | 5466 | 0.150 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 505 | 0.150 |
Why?
|
| Drug Interactions | 2 | 2015 | 245 | 0.150 |
Why?
|
| Anhedonia | 1 | 2017 | 11 | 0.150 |
Why?
|
| Progesterone | 1 | 2017 | 110 | 0.140 |
Why?
|
| Designer Drugs | 2 | 2013 | 4 | 0.140 |
Why?
|
| Estradiol | 1 | 2017 | 250 | 0.140 |
Why?
|
| Pharmacogenomic Variants | 1 | 2016 | 42 | 0.140 |
Why?
|
| Comorbidity | 2 | 2017 | 948 | 0.140 |
Why?
|
| Principal Component Analysis | 2 | 2016 | 160 | 0.140 |
Why?
|
| Premenstrual Syndrome | 1 | 2016 | 2 | 0.140 |
Why?
|
| Self-Control | 1 | 2016 | 11 | 0.140 |
Why?
|
| Receptors, Oxytocin | 1 | 2016 | 10 | 0.140 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 36 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2016 | 114 | 0.130 |
Why?
|
| Panic Disorder | 1 | 2015 | 21 | 0.130 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 108 | 0.130 |
Why?
|
| Craving | 1 | 2016 | 22 | 0.130 |
Why?
|
| Cadherins | 1 | 2016 | 163 | 0.130 |
Why?
|
| Visual Analog Scale | 1 | 2015 | 16 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2015 | 30 | 0.130 |
Why?
|
| Cross-Over Studies | 2 | 2016 | 389 | 0.130 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 82 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2021 | 4273 | 0.130 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 491 | 0.120 |
Why?
|
| Social Class | 1 | 2015 | 135 | 0.120 |
Why?
|
| Time Factors | 2 | 2014 | 5320 | 0.110 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 1670 | 0.110 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2013 | 7 | 0.110 |
Why?
|
| Drug and Narcotic Control | 1 | 2013 | 7 | 0.110 |
Why?
|
| Diphenhydramine | 1 | 2013 | 17 | 0.110 |
Why?
|
| Breath Tests | 1 | 2013 | 57 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2015 | 165 | 0.110 |
Why?
|
| Alcoholism | 1 | 2015 | 178 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 2399 | 0.110 |
Why?
|
| Euphoria | 1 | 2013 | 43 | 0.110 |
Why?
|
| Emergency Treatment | 1 | 2013 | 44 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2016 | 443 | 0.110 |
Why?
|
| Photic Stimulation | 2 | 2014 | 501 | 0.110 |
Why?
|
| Linear Models | 1 | 2014 | 421 | 0.110 |
Why?
|
| Fear | 1 | 2013 | 79 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 20 | 0.100 |
Why?
|
| New York | 1 | 2012 | 72 | 0.100 |
Why?
|
| HIV Infections | 1 | 2021 | 835 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2015 | 321 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2023 | 9003 | 0.100 |
Why?
|
| Research Design | 1 | 2015 | 597 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2752 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1715 | 0.090 |
Why?
|
| Work | 1 | 2010 | 15 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2012 | 187 | 0.090 |
Why?
|
| Hemodynamics | 1 | 2014 | 729 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2023 | 2863 | 0.080 |
Why?
|
| Administration, Cutaneous | 2 | 2020 | 60 | 0.080 |
Why?
|
| Adrenergic Agents | 1 | 2007 | 6 | 0.080 |
Why?
|
| Wakefulness | 1 | 2008 | 135 | 0.080 |
Why?
|
| Fatigue | 1 | 2008 | 179 | 0.080 |
Why?
|
| Behavior | 1 | 2007 | 85 | 0.070 |
Why?
|
| Homosexuality | 1 | 1987 | 9 | 0.070 |
Why?
|
| Orientation | 1 | 2007 | 119 | 0.070 |
Why?
|
| Judgment | 1 | 2007 | 67 | 0.070 |
Why?
|
| Mother-Child Relations | 1 | 1987 | 26 | 0.070 |
Why?
|
| Maternal Behavior | 1 | 1987 | 54 | 0.070 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 154 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 1990 | 509 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 705 | 0.060 |
Why?
|
| Models, Genetic | 1 | 1990 | 944 | 0.060 |
Why?
|
| Chewing Gum | 1 | 2024 | 4 | 0.060 |
Why?
|
| Psychometrics | 2 | 2015 | 329 | 0.060 |
Why?
|
| Multifactorial Inheritance | 2 | 2015 | 169 | 0.060 |
Why?
|
| Baths | 2 | 2013 | 8 | 0.060 |
Why?
|
| Salts | 2 | 2013 | 16 | 0.060 |
Why?
|
| Menthol | 1 | 2022 | 3 | 0.050 |
Why?
|
| Ice | 1 | 2022 | 11 | 0.050 |
Why?
|
| Focus Groups | 1 | 2023 | 170 | 0.050 |
Why?
|
| Biological Evolution | 1 | 1990 | 964 | 0.050 |
Why?
|
| Laboratories | 1 | 2022 | 44 | 0.050 |
Why?
|
| Needle Sharing | 1 | 2021 | 15 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3657 | 0.050 |
Why?
|
| Psycholinguistics | 1 | 2020 | 10 | 0.040 |
Why?
|
| Adolescent Health | 1 | 2019 | 5 | 0.040 |
Why?
|
| Semantics | 1 | 2020 | 48 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 171 | 0.040 |
Why?
|
| Temperament | 1 | 2019 | 27 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 133 | 0.040 |
Why?
|
| Tobacco, Smokeless | 1 | 2018 | 10 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2019 | 221 | 0.040 |
Why?
|
| Multilevel Analysis | 1 | 2016 | 24 | 0.040 |
Why?
|
| Saliva | 1 | 2017 | 123 | 0.030 |
Why?
|
| Diet | 1 | 2020 | 442 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 261 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2019 | 575 | 0.030 |
Why?
|
| Ganglionic Stimulants | 1 | 2015 | 7 | 0.030 |
Why?
|
| Neuroticism | 1 | 2015 | 5 | 0.030 |
Why?
|
| Cell Phone | 1 | 2016 | 38 | 0.030 |
Why?
|
| Placebos | 1 | 2016 | 214 | 0.030 |
Why?
|
| Guanylate Kinases | 1 | 2015 | 12 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 69 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2015 | 9 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2015 | 17 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 373 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 167 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2016 | 222 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2018 | 771 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8203 | 0.030 |
Why?
|
| Data Collection | 1 | 2015 | 375 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 174 | 0.030 |
Why?
|
| Psychological Tests | 1 | 2014 | 91 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 901 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 684 | 0.030 |
Why?
|
| Social Marketing | 1 | 2013 | 10 | 0.030 |
Why?
|
| Poison Control Centers | 1 | 2013 | 18 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 313 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2015 | 187 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2013 | 53 | 0.030 |
Why?
|
| Global Health | 1 | 2013 | 186 | 0.020 |
Why?
|
| Visual Perception | 1 | 2014 | 326 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6777 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 1990 | 324 | 0.020 |
Why?
|
| Child Rearing | 1 | 1987 | 6 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 1987 | 9 | 0.020 |
Why?
|
| Gender Identity | 1 | 1987 | 53 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2007 | 219 | 0.020 |
Why?
|
| Psychotherapy | 1 | 1987 | 73 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2335 | 0.020 |
Why?
|
| Life Style | 1 | 1987 | 172 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 299 | 0.020 |
Why?
|
| Social Support | 1 | 1987 | 208 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 19077 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1987 | 3717 | 0.010 |
Why?
|
| Child | 1 | 1987 | 7149 | 0.010 |
Why?
|
| Animals | 1 | 1990 | 27317 | 0.010 |
Why?
|